ICAM-3/CD50, His, Human
ICAM-3/CD50, His, Human

ICAM-3/CD50, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

ICAM-3/CD50, His, Human

ICAM-3 interacts with LFA1, and is involved in the intercellular adhesion of leukocytes as well as in the mainenance of cell survival. ICAM-3 expression induces cancer cell proliferation, and an increase in ICAM-3 expression can contribute to cancer progression.
Z05391
¥63,425.00

Ask us a question
Product Introduction
Species Human
Protein Construction
ICAM-3/CD50 (Gln30-His485)
Accession # CAA49369.1
His
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 50.54 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 80-110 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • ICAM-3/CD50, His, Human
  • ICAM-3/CD50, His, Human

    ICAM-3/CD50, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background ICAM-3 interacts with LFA1, and is involved in the intercellular adhesion of leukocytes as well as in the mainenance of cell survival. ICAM-3 expression induces cancer cell proliferation, and an increase in ICAM-3 expression can contribute to cancer progression.
Synonyms Intercellular adhesion molecule 3; ICAM3; CDw50; ICAM-R; CD50

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.